Shopping Cart

Request a Demo or a Quote

Your contact information:
Product Information:
We are engineers, scientists and customer service representatives who
Design, build, and support flow cytometers.

Excellence in Cytometry

Cytek® Biosciences Inc. is a leading manufacturer and supplier of flow cytometry products and services. Cytek's compact, affordable instruments and wide ranging support offerings are used by researchers and clinicians all over the world.

Flow cytometry is a powerful analytical tool used for identifying and quantifying cellular characteristics on a cell-by-cell basis up to tens of thousands of cells per second. This technology is used in research and clinical studies with various biomedical and therapeutic applications such as investigating the role of the body's immune system in fighting cancer, diagnosing leukemia and lymphoma, and detecting minimal residual disease in organ transplant patients. Flow cytometry has many advantages over traditional microscopy since it enables the analysis of a greater number of cells in a fraction of the time.

At Cytek, we are focused on accelerating the adoption of flow cytometry for one simple reason: to fuel scientific discovery.

We have leveraged our highly experienced, best-in-the-business team to bring forth an innovative new class of flow cytometry solutions. These solutions deliver deep biological insights at an affordable price, provide high-end capabilities, and bring simplified workflows to more researchers than ever before.

As a Company, we seek to maintain high ethical standards and a culture that values honesty, integrity and transparency in all that we do.

Company decisions are driven by what is right for scientific discovery and customer support. We are committed to our employees, to the environment in which we live and to the communities we serve worldwide.

Cytek® is headquartered in Fremont, California with branch offices and distribution channels across the globe. For more information, visit

Leadership Team

Our team has a unique balance of Financial, Technical, and Operational Management experience focused on agile product development and efficient operations. Our Leaders emphasize delivering Customer Value through Technical Innovation and Superior Customer Service

Wenbin Jiang Ph.D.
Chief Executive Officer
Ming Yan Ph.D.
Chief Technology Officer
Ken Riley, PMP
General Manager
Patrik Jeanmonod
Chief Financial Officer
Steve Ziganti
VP of Worldwide Sales
Ray Lannigan
VP of U.S. Sales
Gil Reinin
Director of Marketing, Research
Mark Herberger
Director of Marketing, Clinical

Join Our Team

Cytek® is a growing company that is always looking for energetic, educated professionals. Expand your possibilities professionally and personally, and join us.

View Job Listings

Board of Directors

Wenbin Jiang Ph.D.
Cytek Biosciences, C.E.O.

Dr. Jiang is a co-founder of Cytek Biosciences, Inc. and a seasoned entrepreneur and inventor. E2O communications was the first company he cofounded in late 1990s, which was acquired by JDS Uniphase in 2004. He is an inventor of more than 90 US patents and an author of 4 book chapters and more than 50 peer reviewed technical papers.

Xin Huang MD Ph.D.
Managing Partner, Cowin Venture

Dr. Xin Huang received his MD from Peking Union Medical College and PhD in Pharmacology and Molecular Sciences from School of Medicine, Johns Hopkins University. He then worked at Boston Consulting Group before he started his VC career in Omaha Capital. In 2012 he joined Cowin Venture and led the firm’s business in Healthcare sector. He has invested about 40 early stage healthcare start-ups in both China and the US during the past several years.

Ming Yan Ph.D.
Cytek Biosciences, C.T.O.

Dr. Yan is a co-founder of Cytek Biosciences, Inc. with over 20 years of R&D experience in leadership and innovation. Prior to Cytek®, Dr. Yan held research and development positions at AT&T Bell Laboratories, Lawrence Livermore National Labs and BD Biosciences. He is one of the thought-leaders in flow cytometry instrumentation and standardization. Dr. Yan has published several research papers relating to laser spectroscopy and cell analysis in top peer-reviewed journals. He has over a dozen patents and patent pending applications for his innovations.

Jack Ball
Solulink Inc., C.E.O.

Jack Ball is CEO and a board member at Solulink Inc. He is President of Tyball Associates, LLC. In addition, he serves on the board of directors of Aquaro Histology, Carterra, Celsee Diagnostics, Cytek Biosciences Inc., NanoCellect Inc. and Swift Bioscience. Most recently he was CCO at Accuri Cytometers, which was sold to Becton Dickinson in March 2011. Prior to Accuri Cytometers, he was CEO of Amnis Corporation, and has also served as CCO for Molecular Probes, Inc. Prior to that he was with Orchid Biosciences as Sr. VP and General Manager and with Amersham Pharmacia Biotech Inc., where he rose to President for North Amercia.

Feng Deng
Northern Light Venture Capital

Mr. Feng Deng founded Northern Light Venture Capital (NLVC) in 2005. He has led and backed nearly 200 companies, focusing on 4 main sectors: TMT (technology, media and telecom), clean technology, healthcare and consumer. Prior to NLVC, Feng was a co-founder of NetScreen Technologies, which went public on NASDAQ and was later acquired by Juniper Networks in 2004 for US$ 4.2 billion. Feng is recipient of Ernst & Young Entrepreneur of the Year (2002) and CRN Innovator of the Year (2003) awards. He has extensive technical and managerial experiences in computer, communication and data networking industries. Feng holds BS and MS degrees in electrical engineering from Tsinghua University, a MS degree in computer engineering from the University of Southern California, and a MBA degree from the Wharton School, University of Pennsylvania. He also holds numerous patents of invention in computer system architecture and IC design.

Dr. Yu Fang
3E-Bioventures Capital

Dr. Francine Fang joined 3E Bioventures as partner in May 2015. Prior to 3E Bioventures, Francine worked at Fidelity Growth Partners Asia (FGPA) as venture partner from 2014-2015. She led the investment transactions of Eyebright and Cytoville (Cytek). From 1998 to 2007, Francine worked at Clontech and BD Biosciences as a group leader in R&D for near 10 years in US. She led the assay development for high content screening in BioImaging group at BD Biosciences in San Jose. Before BD acquisition she led the cell biology group at Clontech for the commercialization of multi-color fluorescent proteins and signal transduction product. From 1996 to 1997, Francine worked as a postdoctor in Physiology at University of Medicine and Dentistry of New Jersey. She got Postdoctoral Fellowship from American Heart Association. Francine has Ph.D. degree in Physiology and Neuroscience at University of Medicine and Dentistry of New Jersey and M.D. degree in Medicine at Capital Institute of Medicine in Beijing China.

Dr. Allen Poirson

Dr. Poirson is an experienced life science executive and entrepreneur. Currently the Senior Vice President of Biopharmaceutical Business Development at twoXAR, he previously served as CEO and Chair of Sony Biotechnology. Dr. Poirson's domain expertise includes analytic instruments, computational biotechnology, medical devices, in vitro diagnostics, chemistry, and software. Allen has formal scientific training in neuroscience and has held research positions at Howard Hughes Medical Institute and NASA. Dr. Poirson obtained his PhD from Stanford.

Zheng Yuan
Shanghai Kinetic Co., Ltd.

Mr. Yuan Zheng Director and CEO. Worked in Chinese Academy of Preventive Medicine; Founder and General Manager of Former Shanghai Moore Biotech Co., Ltd.; Founder of KMC in 2005.

Scientific Advisory Board

Diether J. Recktenwald Ph.D.
Principal at Desatoya LLC
Bob Hoffman
Consultant in Flow Cytometry and Biophotonics
Holden Maecker Ph.D.
Professor of Microbiology and Immunology at Stanford University
Fred Preffer Ph.D.
Professor of Pathology
Dr. rer. nat. Andreas Radbruch
Professor at Deutsches Rheuma-Forschungszentrum – Berlin, Germany
Dr. Bill Telford
Associate Scientist and director of the flow cytometry core laboratory in the NCI Experimental Transplantation and Immunology Branch.


De Novo Software is a leading provider of flow and image cytometry analysis. Its primary product, FCS Express, is used by over 3,000 laboratories worldwide for research purposes, and dozens of clinical laboratories for high-throughput clinical analysis. As the first third-party flow analysis software listed with the FDA for in-vitro diagnostic use, and with full 21 CFR Part 11 compliance features, FCS Express is the analysis tool of choice for the clinical laboratory. In addition, De Novo Software has extensive experience creating custom data analysis solutions and integrating with large scale LIS and HIS systems. For more information, please visit
Did you miss our webinar with De Novo Software? You'll learn how to work with your spectral analysis data files directly in FCS Express, how our complementary technologies are designed to get you results in record time, and more.


United States - West Coast
46107 Landing Parkway
Fremont, CA 94538-6407

United States - East Coast
6420 Seminole Trail STE4
Barboursville, VA 22923-2836

Amstelveenseweg 648
1081 JJ, Amsterdam
The Netherlands

"EDGE" Building
2-9-1 Ikenohata Taito-ku
Tokyo 110-0008 Japan

560 Shengxia Road, Suite 603
Zhangjiang High-Tech Park
Shanghai Pilot Free Trade Zone, 201203
Phone: 86-21-60897568
Fax: 86-21-60897570